Viemed Healthcare Inc. reported net revenues of $71.9 million for the quarter ended September 30, 2025, an increase of 24.0% or $13.9 million over the same period in 2024. Net income attributable to Viemed for the quarter was $3.5 million, or $0.09 per diluted share. Adjusted EBITDA reached $16.1 million, up 15.5% compared to the prior year quarter. Net cash provided by operating activities was $18.4 million for the quarter, with free cash flow of $12.4 million. During the period, Viemed completed the acquisition of Lehan's Medical Equipment on July 1, 2025, which was immediately accretive to net income and earnings per share. The company completed its 2025 share repurchase program and updated its adjusted EBITDA guidance for the year to a range of $60.0 million to $62.0 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viemed Healthcare Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1097432) on November 05, 2025, and is solely responsible for the information contained therein.
Comments